Stephen Basso
Senior Vice President, Finance, Inozyme Pharma, Inc.
Companies
- Innoviva, Inc.Chief financial officer Aug 31, 2023 to now1
- Inozyme Pharma, Inc.Senior Vice President, Finance Jul 23, 2020 to Mar 25, 20212
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Innoviva, Inc. INVA88,013 shares3$1.8M at $20.86Aug 20, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 20, 2026Shares withheld for tax 558 shares at $21.00 of Innoviva, Inc.3
- May 20, 2026Shares withheld for tax 559 shares at $22.24 of Innoviva, Inc.4
- May 15, 2026Granted 1,123 shares of Innoviva, Inc.4
- May 4, 2026Granted 37,994 shares of Innoviva, Inc.5
- Feb 20, 2026Shares withheld for tax 1,244 shares at $23.39 of Innoviva, Inc.6
- Nov 20, 2025Shares withheld for tax 237 shares at $21.16 of Innoviva, Inc.7
- Nov 15, 2025Granted 604 shares of Innoviva, Inc.7
- Nov 3, 2025Granted 27,609 shares at $18.11 of Innoviva, Inc.8
- Aug 20, 2025Shares withheld for tax 237 shares at $19.95 of Innoviva, Inc.9
- May 20, 2025Shares withheld for tax 237 shares at $18.78 of Innoviva, Inc.10
- May 15, 2025Granted 1,353 shares of Innoviva, Inc.10
- Feb 24, 2025Granted 10,569 shares at $18.08 of Innoviva, Inc.11
- Feb 20, 2025Shares withheld for tax 1,106 shares at $18.07 of Innoviva, Inc.12
- Nov 15, 2024Granted 843 shares of Innoviva, Inc.12
- Mar 5, 2024Granted 12,096 shares at $14.88 of Innoviva, Inc.13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed May 22, 2026
- 5SEC EDGARForm 4 filed May 6, 2026
- 6SEC EDGARForm 4 filed Feb 24, 2026
- 7SEC EDGARForm 4 filed Nov 24, 2025
- 8SEC EDGARForm 4 filed Nov 5, 2025
- 9SEC EDGARForm 4 filed Aug 22, 2025
- 10SEC EDGARForm 4 filed May 22, 2025
- 11SEC EDGARForm 4 filed Mar 26, 2025
- 12SEC EDGARForm 4 filed Feb 24, 2025
- 13SEC EDGARForm 4 filed Mar 7, 2024